Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth

Completed

Conditions studied: Transgendered Persons

In brief

This study plans to learn more about puberty blockers and cross (testosterone and estradiol). There is not much known about how these medications affect hormone levels, heart health and overall general health in young transgender individuals.

Key facts

Study ID

NCT02550431

Run by

University of Colorado, Denver

People needed

58

Starts

2016-03-01

Expected to finish

2018-01-26

Last updated by the study team

2018-02-05

Who can join

Age: 9 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Followed in Endocrinology Clinic or Adolescent Medicine Clinic at Children's Hospital Colorado
• Between age 9 and 21 years (inclusive)
• Identifies as transgender
• Has been on pubertal blockade or cross-sex hormones for at least three months.

You may not qualify if…

• Known diabetes
• Presence of significant medical or psychiatric comorbidities
• Using hormones not prescribed by a physician

Where it is running

• Children's Hospital Colorado — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.